MARKSANS PHARMA
Back to Balance Sheet
|
MARKSANS PHARMA Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹205 Cr | ₹84 Cr | ₹57 Cr | ₹24 Cr | ₹24 Cr |
What is the latest Total Non-Current Liabilities ratio of MARKSANS PHARMA ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹205 Cr |
Mar2023 | ₹84 Cr |
Mar2022 | ₹57 Cr |
Mar2021 | ₹24 Cr |
Mar2020 | ₹24 Cr |
How is Total Non-Current Liabilities of MARKSANS PHARMA Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹205 Cr | 143.34 | |
Mar2023 | ₹84 Cr | 47.80 | |
Mar2022 | ₹57 Cr | 140.72 | |
Mar2021 | ₹24 Cr | -1.88 | |
Mar2020 | ₹24 Cr | - |
Compare Total Non-Current Liabilities of peers of MARKSANS PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MARKSANS PHARMA | ₹11,096.6 Cr | 1.7% | -15.4% | 57.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹423,974.0 Cr | 1.3% | -4.7% | 22.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹161,729.0 Cr | 6.3% | 3.3% | 59.2% | Stock Analytics | |
CIPLA | ₹116,999.0 Cr | -0.7% | -3.3% | 2.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,771.0 Cr | 2.1% | -9.7% | -0.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,951.9 Cr | 2.1% | -2.8% | 26.4% | Stock Analytics |
MARKSANS PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MARKSANS PHARMA | 1.7% |
-15.4% |
57.7% |
SENSEX | 2.7% |
0.8% |
9.7% |
You may also like the below Video Courses